T.Man Pharmaceutical Public Company Limited

SET:TMAN Stock Report

Market Cap: ฿6.2b

T.Man Pharmaceutical Future Growth

Future criteria checks 3/6

T.Man Pharmaceutical is forecast to grow earnings and revenue by 17.4% and 11.7% per annum respectively while EPS is expected to grow by 3.5% per annum.

Key information

17.4%

Earnings growth rate

3.5%

EPS growth rate

Pharmaceuticals earnings growth16.7%
Revenue growth rate11.7%
Future return on equityn/a
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SET:TMAN - Analysts future estimates and past financials data (THB Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252,5165361835141
12/31/20242,2094521284141
9/30/20242,197433313514N/A
6/30/20242,130419239416N/A
3/31/20242,055425151349N/A
12/31/20231,98043162282N/A
9/30/20231,90341697387N/A
6/30/20231,982494269597N/A
3/31/20232,003483279560N/A
12/31/20222,025473289524N/A
12/31/20211,26356196276N/A
12/31/202090160129194N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TMAN's forecast earnings growth (17.4% per year) is above the savings rate (2%).

Earnings vs Market: TMAN's earnings (17.4% per year) are forecast to grow faster than the TH market (16.9% per year).

High Growth Earnings: TMAN's earnings are forecast to grow, but not significantly.

Revenue vs Market: TMAN's revenue (11.7% per year) is forecast to grow faster than the TH market (6.5% per year).

High Growth Revenue: TMAN's revenue (11.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TMAN's Return on Equity is forecast to be high in 3 years time


Discover growth companies